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Abstract 
Phenothiazines are a large group of heterocyclic, aromatic molecules with nitrogen and
sulphur between two benzene rings. Their derivatives, N-alkylphenothiazines have sub-
stituent on heterocyclic nitrogen atom which gives them different properties. Also, a series
of these molecules have substitution on carbon atom at place 2 of phenothiazine benzene
ring. Alkylphenothiazines contain aminoalkyl substituent and their alkyl, acyl and sulphonil
derivatives, as well as monocyclic and bicyclic heterocycles attached at thiazine nitrogen
atom or directly linked to benzene ring. The N-alkylphenothiazines have been known as
antipsychotic drugs, but they also possess antibacterial, antifungal, anticancer activity, and
ability to react with macromolecules and to coordinate to the metals. Metal complexes
with N-alkylphenothiazines are biological active compounds with different antimicrobial
activities and cytotoxic effect against tumor cell lines. The large field of application of
N-alkylphenothiazines is very attractive in terms of synthesis of new related derivatives,
metal complexes, studying their properties and applications. This article presents a review 
of the literature and a contemporary view at N-alkylphenothiazines – their synthesis and 
application, as well as their metal complexes which have promising biological effects. 
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The N-alkylphenothiazines are heterocyclic aro-
matic compounds with nitrogen and sulphur atoms and 
substituents on aromatic ring and nitrogen. The central 
place of these molecules is a molecule of 10H-dibenzo- 
-1,4-thiazine, phenothiazine (Fig. 1) known more than a 
hundred years [1]. 
 
Figure 1. Structure of the 10-H-dibenzo-1,4-thiazine, pheno-
thiazine. 
The first phenothiazines, thionine and methylene 
blue (Fig. 2) were synthesized in reaction of p-phenyl-
endiamine/p-aminodimethylaniline with sulphur in 
hydrochloric acid solution, in the middle of the 19th 
century [2]. In that time, these compounds with pheno-
thiazine ring had an application in aniline dye industry.  
After 20 years, the parent compound, 10H-dibenzo- 
-1,4-thiazine was obtained in reaction of diphenylamine 
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with sulphur by Bernthsen (Scheme 1). Until today, 
more than 5000 phenothiazine derivatives were syn-
thesized with wide range of application [1]. 
Phenothiazines have many different applications, 
from industry to medicine. As biological active com-
pounds, these molecules have antipsychotic, antieme-
tic, anthelmintic, antibacterial, antifungal and insectic-
idal properties, and they also represent promising anti-
cancer drugs [1–8]. These activities represent the result 
of the interaction of phenothiazines with biological 
systems through their pharmacophoric substituent, the 
multicyclic ring system (π-π interaction, intercalation in 
DNA) or the lipophilic character allowing the penet-
ration through the biological membranes. The activities 
were examined by using various biological systems 
such as cell lines, bacteria, viruses, parasites, laboratory 
mice, rats and rabbits, and monolayer and bilayer 
membranes [2]. The N-alkylphenothiazines as ligands 
are used in metal complexes, but biological properties 
of these complexes are investigated in recent years. 
This review shows current importance of the N-alkyl-
phenothiazines and reveals their metal complexes as 
potent pharmacological group which can be a rich 
source of new compounds having desirable biological 
activities. 
Structure of N-alkylphenothiazines 
Most often, phenothiazines have substituted hyd-
rogen atoms at position 2 (with some small molecule) 
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and position 10 (with aminoalkyl groups). At this point, 
N-alkylphenothiazines (Figure 3) are classified into three 
groups depending on the type of the substitution on 
the nitrogen atom of phenothiazine ring [9,10]. First 
group contains phenothiazines with an aliphatic side 
chain, then the second group with the piperidine, and 
the third group contains piperazine derivatives (Table 1). 
 
Figure 3. General structure of N-alkylphenothiazine.
 
Table 1. N-alkylphenothiazines classification depends on the type of substituent on N-10 and C-2 atoms 
Compound R1 R2 
Phenothiazines with an aliphatic side chain 
Promazine (Pr) (CH2)3–N(CH3)2 H 
Chlorpromazine (Cpz) (CH2)3–N(CH3)2 Cl 
Triflupromazine (Tm) (CH2)3–N(CH3)2 CF3 
Methotrimeprazine (Mtm) CH2–CH(CH3)–N(CH3)2 OCH3 
Phenothiazines with a piperidine side chain 
Thioridazine (Tr) 
N
CH3
(CH2)2
S(CH3) 
Mesoridazine (Mr) 
N
CH3
(CH2)2
SO(CH3) 
Sulphoridazine (Sr) 
N
CH3
(CH2)2
OSO(CH3) 
Phenothiazines with a piperazine side chain 
Prochlorperazine (Pc) 
N
N CH3
(CH2)3
Cl 
Trifluoperazine (Tf) 
N
N CH3
(CH2)3
CF3 
Perphenazine (Pz) 
N
N CH2
(CH2)3
CH2OH
 
Cl 
 
Figure 2. Structure of the 3,7-diamino-5-phenothiazinium acetate (thionine) and  3,7-bis(dimethylamino)phenazathionium chloride 
(methylene blue). 
 
Scheme 1. Synthesis of 10-H-dibenzo-1,4-thiazine (phenothiazine). 
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Table 1. Continued 
Compound R1 R2 
Phenothiazines with a piperazine side chain 
Fluphenazine (Fz) 
N
N CH2
(CH2)3
CH2OH
 
CF3 
Thioprozapate (Tp) 
N
N CH2
(CH2)3
CH2OCOCH3
 
Cl 
 
The new derivatives of phenothiazines are syn-
thesized from the parent phenothiazines in several dir-
ections: substitution of new groups with the thiazine 
nitrogen atom [11], an introduction of a new sub-
stituent at positions 1–4 and 6–9 aromatic rings, oxid-
ation of the sulfide sulfur atom to a sulfoxide or sulfone 
group, as well as a substitution one or both benzene 
ring with homoaromatic or heteroaromatic rings [1]. 
Synthesis of N-alkylphenothiazines 
Promazine, N,N-dimethyl-3-(10H-phenothiazin-10- 
-yl)-propan-1-amine, is synthesized by the alkylation of 
phenothiazines with 3-dimethylaminopropylchloride in 
the presence of sodium amide (Scheme 2) [12].  
Chlorpromazine, 3-(2-chloro-10H-phenothiazin-10- 
-yl)-N,N-dimethyl-propan-1-amine is prepared follow-
ing two steps: in the first step, 3-chlorodiphenylamine 
with sulphur gives as product 2-chloro-10H-pheno-
thiazine, while in the second step, this compound 
reacts with 3-dimethylaminopropylchloride, similar to 
the synthesis of promazine (Scheme 3) [12]. 
Trifluopromazine, N,N-dimethyl-3-[2-(trifluoro-
methyl)-10H-phenothiazin-10-yl]propan-1-amine (Fig. 
4) is also prepared by alkylation of 2-trifluoromethyl- 
-10H-phenothiazine in the presence of sodium amide 
[12]. 
 
Figure 4. Structure of the N,N-dimethyl-3-[2-(trifluoromethyl)- 
-10H-phenothiazin-10-yl]propan-1-amine, (trifluopromazine). 
A series of molecules has substitution on carbon 
atom at position 2 of phenothiazine benzene ring of 
promazine as methopromazine (possess methoxy 
group) and acetopromazine (with aceto group on C-2 
atom) which are synthesized in similar way.  
Phenothiazines with a piperidine side chain, thio-
ridazine 10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methyl-
thio)-10H-phenothiazine and mesoridazine 10-[2-(1- 
-methyl-2-piperidyl)ethyl]-2-(methylsulfinyl)-10H-pheno-
thiazine are also synthesized by alkylation of methyl-
sulphonil-10H-phenothiazine/2-methylthio-10H-pheno-
 
Scheme 2. Synthesis of N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine(promazine). 
 
Scheme 3. Synthesis of 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-propan-1-amine (chlorpromazine). 
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thiazine using 2-(2-chloroethyl)-1-methylpiperidine in 
the presence of sodium amide (Scheme 4) [12]. 
At last, phenothiazines with piperazines chain, pro-
chlorperazine, 2-chloro-10-[3-(4-methyl-1-piperazinyl)-
propyl]-10H-phenothiazine and trifluoperazine, 10-[3- 
-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)- 
-10H-phenothiazine are prepared by alkylation of 
2-chloro-10H-phenothiazine/2-trifluoromethyl-10H-phe-
nothiazine using 4-methyl-1-piperazinylpropylchloride 
in presence of sodium amide (Scheme 5) [12]. 
 
Perphenazine, 2-[4-[3-(2-chloro-10H-phenothiazin- 
-10-yl)propyl]piperazin-1-yl]ethanol, and fluphenazine, 
2-[4-[3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)pro-
pyl]piperazin-1-yl]ethanol, are synthesized in a similar 
way as previously described. In the first step, 2-chloro- 
-10H-phenothiazine/2-trifluoromethyl-10H-phenothia-
zine is alkylated using 4-formyl-1-piperazinylpropyl-
chloride in the presence of sodium amide and then 
N-formyl group was removed by alkaline hydrolysis 
giving the intermediate product (Scheme 6). The final 
step is alkylation of intermediate compound by 2-bro-
 
Scheme 4. Synthesis of 10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)-10H-phenothiazine (thioridazine, R1) and 10-[2-(1-methyl-2-
-piperidyl)ethyl]-2-(methylsulfinyl)-10H-phenothiazine (mesoridazine, R2). 
 
Scheme 5. Synthesis of 2-chloro-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine (prochlorperazine, R1) and 10-[3-(4-methyl-
piperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine (trifluoperazine, R2). 
 
Scheme 6. Synthesis of 2-[4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl]ethanol (perphenazine, R1) and 2-[4-[3-[2-(tri-
fluoromethyl)-10H-phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol (fluphenazine, R2).
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methanol-1-acetate by acid hydrolysis which removes 
acetyl group [12]. Also, these molecules contain an 
alcohol group which provides an opportunity for deri-
vatization in order to obtain new compounds with 
pharmacological using. 
Use and application 
The phenothiazine group of compounds has the 
great spectrum of application from industry to medi-
cine for more than a century due to their diverse syn-
theses. Substituted phenothiazines have been used for 
the preparation of the polymers [13], the solar cells 
[14,15], biological stains [16], as well as medicaments 
[12]. They possess antimicrobial [6,21–24], anthelmin-
tic [7], antiemetic [8], antihistaminic [8] anticancer pro-
perties [2], and they are used in clinical practice more 
than 50 years as antipsychotics [12,17].  
In many researches, it was shown that N-alkylphe-
nothiazines possess antimicrobial activity [18–20]. Kris-
tiansen et al. [18] demonstrated that chlorpromazine 
and thioridazine reduce the susceptibility of methicillin-
resistant Staphylococcus aureus (MRSA) while Martins 
et al. [19] in their research classified a few N-alkyl-
phenothiazines as non-antibiotics (helper compounds) 
in the treatment of multidrug resistant Gram-negative 
infections. As anthelmintics, phenothiazines reduced 
faecal eggs of resistant strains of three nematodes, 
Haemonchus contortus, Trichostrongylus colubriformis 
and Ostertagia spp., but without significant effect on 
worm number [7]. 
Phenothiazines have been shown to inhibit in vitro 
growth of multi drug resistance strain (resistant to rif-
ampin and isoniazid) Mycobacterium tuberculosis. The 
killing of intracellular bacteria promoted by phenothia-
zine can inhibit many transport processes of potassium 
and calcium pump activation. The increased perme-
ability ensures phenothiazine molecules to reach the 
DNA, intercalate between the bases, inhibit the entire 
DNA and hence inhibit transcription and translation 
processes [21]. The ability of chlorpromazine to cure 
tuberculosis resulted in a series of in vitro studies that 
showed that chlorpromazine was more effective anti-
mycobacterial compound than other N-alkylpheno-
thiazines [21–24]. Because chronic administration of 
chlorpromazine is known to produce a wide range of 
mild-to-severe side effects, the use of this compound in 
tuberculosis therapy was not seriously considered.  
Thioridazine can more effectively accelerate the rec-
overy of infected mice from Mycobacterium tuber-
culosis, as shown in preliminary study [24], providing 
strong direct evidence that thioridazine, a neuroleptic 
that is milder and less toxic than chlorpromazine, kills 
intracellular Mycobacterium tuberculosis isolates that 
are resistant to two or more antibiotics [22]. These 
investigations indicate that phenothiazines have been 
considered as an adjuvant for the treatment of Myco-
bacterium tuberculosis. 
The blockade of histamine receptors in brain gives 
sedative effect to the most of N-alkylphenothiazines. 
Prochlorperazine, promethazine and perphenazine are 
known as antipsychotic drugs which block postsynaptic 
dopaminergic receptors in the brain and have antieme-
tic effects by their antagonic actions in the dopamine 
receptors (D2) predominantly, but also may possess 
antagonist actions at histamine 1, cholinergic M1 and 
α1-adrenergic receptors in the vomiting center to red-
uce nausea and vomiting [8]. Promethazine hydrochlo-
ride is in pharmacological use as Phenergan cream, 
topical antihistaminic preparation for systemic eczema-
tous dermatitis.  
Phenothiazines as lipophylic molecules are inter-
acting with various macromolecules and possess anti-
cancer activity. Chlorpromazine, promethazine, thiori-
dazine and trifluoperazine, in clinically relevant plasma 
concentrations 2–36 µM, markedly decreased the via-
bility of leukemic cells without any toxic effects on 
normal lymphocytes [25]. Phenothiazines show anti-
proliferative activity against breast, ovarian, lung, CNS, 
prostate and melanoma cell lines. Trifluoperazine, 
chlorpromazine and thioridazine in concentration up to 
20 µM expressed a selective cytotoxicity, as well as 
antiproliferative activity and induced apoptosis [4]. 
Also, N-alkylphenothiazines have the capacity to inc-
rease the lethal effect at low doses of the therapeutic 
drugs [26]. Cytotoxicity of these compounds could be 
attributed to oxidative stress, via glutathione oxidation 
and lipid peroxidation. 
The most common application of phenothiazines is 
in psychiatry [10,17]. Modern psychopharmacology 
cannot be imagined without chlorpromazine. Chlorpro-
mazine was synthesized in 1951 by Paul Charpentier, 
and became available on prescription in France in 1952, 
under the proprietary name of Largactil as pharma-
ceutical drug [17]. In medical practice, chlorpromazine 
is used in the treatment of patients with schizophrenia, 
neurosis, manic-depressive condition and chronic para-
noids, alcoholic psychoses as well as for stress-sampled 
neuroses, insomnia and fears. Promazine and 
triflupromazine have similar application. Trifluopera-
zine is one of the most active antipsychotic drugs with 
common synonyms in pharmacy as stelazine, triftazin 
and others. This drug has strong anticonvulsant activity 
and it is used in treatment for schizophrenia and other 
mental diseases. Mesoridazine has application for 
behavior problems, schizophrenia, chronic alcoholism 
and other. Phenothiazines with aliphatic side chain and 
piperidine substituent have more pronounced sedative 
effect than piperazine derivatives. These molecules are 
non-selective and competitive D1 and D2 antagonists 
that block dopamine activity at corresponding receptor 
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site. Also, their activity could be expressed by blocking 
α-adenoreceptors, serotonine, cholinergic, nicotine and 
muscarinic receptors [12]. 
In the aim of finding new applications of these com-
pounds, they are used as ligands in coordination chem-
istry. Until today many complexes containing N-alkyl-
phenotiazines are synthesized and characterized. 
Gowda and his group [27,28] prepared Ir(III) and Pd(II) 
complexes with N-alkylphenothazines and proposed 
heterocyclic S atom coordination. Keshavan et al. syn-
thesized many complexes of lanthanide with N-alkyl-
phenothiazines indicating that the tertiary nitrogen, as 
well as phenothiazine’s nitrogen, represents the coor-
dination site of ligand [29,30]. Also, complexes of lan-
thanide showed moderately antibacterial activity against 
some Gram-positive and Gram-negative bacteria. The 
structure of lanthanide complexes with phenothiazine 
was determined by X-ray single crystal diffraction anal-
ysis (Fig. 5) displaying lantanide- nitrogen bond [31].  
 
Figure 5. ORTEP diagram of complex (C5H5)2ErPtz(THF) [22]. 
The complex HgCl2(ptz)]2·HgCl2 was synthesized by 
reaction of HgCl2 and phenothiazine in benzene as 
dark-blue powder [32]. The final products were charac-
terized by X-ray diffraction which confirmed S-coor-
dination of phenothiazine (Fig. 6). 
A series of conjugated polymers with bipyridine 
groups were synthesized successfully via Suzuki coup-
ling polycondensation using carbazole and phenothia-
zine as the main chain moieties. Through a one-pot 
post-functionalization reaction, ruthenium complexes 
were introduced into the polymer through a flexible 
spacer in high yields, which lead to a new simplified 
strategy to synthesize this special type of conjugated 
polymer with metal complex linked to pendant groups 
through a flexible chain. Furthermore, the obtained Ru-
containing polymers PM1PT-x-Ru exhibited broad abs-
orption in the visible region, and possessed a narrow 
electrochemical band gap (approximately 1.36–1.42 
eV) and low HOMO energy level (about 5.47–5.34 eV), 
indicating that they are suitable candidates as photo-
sensitive materials for solar cells [33]. 
Platinum complexes with chlorpromazine and tri-
fluoperazine were prepared from K2[PtCl6] in water 
(Scheme 7). Complexes were characterized by spectral 
(IR, 1H, 13C, 2D 1H–13C heteronuclear correlation spec-
tra, 195Pt NMR and MS) analysis. Outer-coordination 
sphere was proposed for ((TFH·HCl)[PtCl5H2O]), while in 
((CP·H)[Pt(CP·HCl)Cl5]·H2O), the ligand was coordinated 
to the metal via heterocyclic sulphur. The complexes 
exhibit antibacterial effect on strains of Bacillus subtilis, 
Bacillus cereus, Bacillus pumilus and methicillin-resist-
ant Staphylococci as Gram-positive bacteria, and an 
Escherichia coli as Gram-negative bacteria, as well as 
the reference strains [34]. 
Ru(II) complexes with N-alkylphenothiazines 
Three new complexes of the general formula 
L[RuCl3(DMSO)3] (1–3), where L is chlorpromazine hyd-
rochloride, trifluoperazine dihydrochloride or thiorida-
zine hydrochloride, were prepared by the reaction of 
the starting complex [RuCl2(DMSO)4] and the corres-
ponding ligands in a mole ratio of 1:1.6 in absolute 
ethanol [35]. The complexes were characterized by ele-
mental analysis and spectroscopic methods. The crystal 
structure of the complex (TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH 
contains trifluoperazine dihydrochloride in outsphere 
position, but its chloride atom had substituted one of 
DMSO molecules in starting complex and coordinated 
to the Ru(II) atom (Fig. 7). 
The investigation of antitumor properties of com-
plexes 1–3 in four human cell lines (MCF-7, MDA-MB- 
-453, SW-480 and IM9) showed dose-dependence and 
 
Figure 6. ORTEP diagram of complex [HgCl2(ptz)]2·HgCl2 [23].
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variation by cell types. The most active compound is 
complex (CP.H)[RuCl3(DMSO)3]·C2H5OH, which demon-
strates a higher activity against MCF-7 and IM9, but it is 
less effective against other cell lines and did not cause 
complete cell death. Complex: 
(TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH 
is the most sensitive against human breast cancer cell 
line (MDA-MB-453) and human colon adenocarcinoma 
cell line (SW-480), while other two complexes were 
active even in low concentrations, and induced almost 
total cell death  at 25 µM during 48 h of treatment. 
Moreover, complex (TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH is 
 
Scheme 7. Reaction scheme for synthesis Pt(II) complexes with chlorpromazine hydrochloride and trifluoperazine dihydrochloride. 
 
Figure 7. Asymmetric unit of (TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH. 
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the only compound in our investigations displaying 
cytotoxic activities against all tumour cell lines. The sel-
ective cytotoxicity of these complexes, especially com-
plex (TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH, against the can-
cer cells suggests their great  potential for development 
as anticancer drugs. It is also investigated the effect of 
this complex on antioxidative enzymes in rat blood. 
Biological assays provide the clear evidence that com-
plex (TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH under physiol-
ogical conditions can act as a scavenger of NO· radicals 
in lower doses of 0.4 and 4.5 µM/kg bw, and as a scav-
enger of free radicals, such as superoxide anion and 
hydroxyl radicals (Fig. 8). This compound also influ-
ences the SOD and CAT activities, even in dose of 90.4 
µM/kg bw. As non-toxic compound under physiological 
conditions, this complex could provide potential thera-
peutic benefits in lower doses (0.4 and 4.5 µM/kg bw) 
for disorders where these reactive species are involved. 
 
Figure 8. Content of NO2–: I – control group; I – rats treated 
i.p. with complex (TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH  at dose of 
0.4 µM/kg bw; III-rats treated i.p. with complex 
(TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH at dose of 4.5 µM/kg bw; 
IV – rats treated i.p. with complex 
(TF.H2)[RuCl3(DMSO)3]Cl·C2H5OH at dose of 90.4 µM/kg bw. 
The thermal decomposition pattern of the starting 
complex [RuCl2(DMSO)4] and complexes L[RuCl3(DMSO)3], 
where L is protonated chlorpromazine hydrochloride, 
trifluoperazine dihydrochloride or thioridazine hydro-
chloride, does not depend on the atmosphere: the 
thermal curves are almost identical in nitrogen and air 
atmospheres [36]. Also, decomposition of these com-
plexes is not completed at 700, but near 1000 °C as 
residue is elemental ruthenium. This property of com-
plexes is in agreement to biological potential and pro-
vides an opportunity for these compounds to adapt to 
different ambient conditions.  
In reaction of N-alkylphenothiazines with [RuCl2(η6- 
-p-cymene)]2 in 2-propanol, after about 3 h, orange 
precipitate was formed. As in previously research, com-
plex with trifluoperazine gave single crystal for X-ray 
analysis (Fig. 9). The crystal structure of complex 2 
contains the Ru center in a pseudo-octahedral “piano- 
-stool” geometry, with p-cymene and three chloride 
ions in the coordination sphere, and N-alkylpheno-
thiazine in the outer-sphere. In vitro cytotoxic activities 
of complexes were assayed in four human carcinoma 
cell lines MCF-7, MDA-MB-453, SW-480 and IM9. The 
highest cytotoxicity (12.1 ≤ IC50 ≤ 17.3 µM) and 
induced a total (SW-480) or almost total cell death 
(MCF-7, MDA-MB-453) at 25 µM in 48 h of treatment 
were observed for complex (TF.H2)[ RuCl3(η6-p- 
-cymene)] Cl·C3H7OH [37]. 
Biological assays provide clear evidence that this 
compound demonstrates a positive effect on the heart 
muscle, as suggested by unchanged LDH1 levels and a 
lower level of LDH2. Complex (TF.H2)[RuCl3(η6-p- 
-cymene)] Cl·C3H7OH inhibited SOD activity in all doses, 
although influence on CAT activity was not observed. 
Results of this study suggest the cardio protective pot-
ential of complex (TF.H2)[ RuCl3(η6-p-cymene)] Cl·C3H7OH, 
since the decreased activity of LDH2 was revealed after 
its oral administration. This investigation illustrates the 
potential of Ru(II)-cymene complexes with pharma-
cologically active substances as novel and promising 
bioinorganic drugs. 
 
 
Figure 9. Asymmetric unit of (TF.H2)[ RuCl3(η6-p-cymene)] Cl·C3H7OH.
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Thermal analysis of these complexes were shown a 
great thermal stability of starting complex [RuCl2(η6-p- 
-cymene)]2, while thermal decomposition of chlorpro-
mazine’s and trifluoperazine’s Ru-complex began at 
low temperature [38].  
CONCLUSIONS 
The phenothiazine belongs to the group of hetero-
cyclic aromatic compounds with nitrogen and sulphur 
atoms. The N-alkylphenothiazines are formed in the 
reaction of substitution on the nitrogen atom of pheno-
thiazines ring with aliphatic side chain, piperidine, pip-
erazine or with some new group of molecule. The other 
substituent is at carbon atoms in position 2 of benzene 
ring, but new generation of N-alkylphenothiazines int-
roduces substituent at position 1-4 and 6-9 at the 
benzene ring. These molecules possess many appli-
cations, but the most important implementation is in 
medicine. They are medicinal drugs with the major 
effect on central nervous system almost irreplaceable 
in treatment of mental diseases. Many of them have 
shown cytotoxic effect against different cancer cell 
lines or in small doses supported the therapeutic drugs 
to lead apoptosis of cancer cells.  
N-alkyphenothiazines are also used in synthesis of 
metal complexes which showed antibacterial activity. 
Complexes of Ru(II) with N-alkylphenothoazines showed 
significant anticancer activity against four cancer lines. 
These complexes possess positive effect in small doses 
on antioxidant enzymes, as well as the complex 
(TF.H2)[ RuCl3(η6-p-cymene)] Cl·C3H7OH demonstrated 
cardio protective potential by decreased activity of LDH2 
isoenzymes. Having into consideration all of the above, 
N-akylphenothiazines have promising potential in both 
bioinorganic chemistry and medicine in the future.  
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IZVOD 
N-ALKILFENOTIAZINI – SINTEZA, STRUKTURA I PRIMENA KAO LIGANADA U KOMPLEKSIMA METALA 
Milena Krstić1, Sofija Sovilj2, Sunčica Borozan1, Milica Rančić3, Jelena Poljarević2, Sanja R. Grgurić-Šipka2 
1Fakultet veterinarske medicine, Univerzitet u Beogradu, Beograd, Srbija 
2Hemijski fakultet, Univerzitet u Beogradu, Beograd, Srbija 
3Šumarski fakultet, Univerzitet u Beogradu, Beograd, Srbija 
(Pregledni rad) 
Fenotiazini pripadaju velikoj grupi heterocikličnih, aromatičnih molekula koji
između dva benzenova prstena sadrže azot i sumpor. Njihovi derivati, N-alkilfeno-
tiazini poseduju supstituent na heterocikličnom azotovom atomu koji molekulima
daje različita svojstva. Takođe, serija ovih jedinjenja ima supstituent i na ugljeni-
kovom atomu u položaju 2 benzenovog prstena fenotiazina. Alkilfenotiazini sadrže
aminoalkil grupu kao supstituent i njegovi alkil, acil i sulfonil derivati, kao i mono- i 
biciklični heterocikli vezani su za tiazinski azotov atom ili direktno za benzenov
prsten. N-alkilfenotiazini su poznati kao antipsihotici, ali poseduju i antibakterij-
sku, antifungalnu, antitumorsku aktivnost, kao i sposobnost da reaguju sa makro-
molekulima i da se koordinuju za jone metala. Kompleksi metala sa N-alkilfenotia-
zinima pokazala su se kao biološki aktivna jedinjenja sa različitom antimikrobnom
aktivnošću i citotoksičnim efektom na različite tumorske ćelijske linije. Upravo
zbog njihovog širokog polja primene N-alkilfenotiazini su veoma atraktivni u
smislu sinteza novih srodnih derivata, komleksa metala, proučavanja njihovih
svojstava i istraživanjima na polju njihove dalje primene. Ovaj rad predstavlja 
pregled literature i savremeni pogled na N-alkilfenotiazine – njihovu sintezu i pri-
menu, kao i njihovih metalnih kompleksa koji poseduju značajna biološka svojstva.
  Ključne reči: N-Alkilfenotiazini • Antipsi-
hotici • Antitumorski efekat • Antibak-
terijski efekat 
 
